Výsledky vyhledávání - "Selamawit Gutema"

Akademický článek

Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus

Autor: Agete Tadewos Hirigo, Selamawit Gutema, Aberash Eifa, Worku Ketema

Publikováno v: SAGE Open Medical Case Reports, Vol 10 (2022)

HIV-infected people have started to live longer since the introduction of antiretroviral therapy, however various co-morbid illnesses have emerged. Three HIV-infected individuals, all at least 43 years old, reported with a new onset of type 2 diabete

Externí odkaz: https://doaj.org/article/96edcd37fd4d44368dab0a5ef9bbedb7

Zobrazit plný text záznamu

A Breakthrough in the Challenges of Tuberculosis Diagnosis: Lateral Flow Urine Lipoarabinomannan (LAM) Assay for the Diagnosis of Active Tuberculosis in a Subset of Human Immuno Deficiency Virus (HIV) Patients at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia

Autor: Worku Ketema, Kindie Woubishet, Sisay Tesfaye, Selamawit Gutema, Kefyalew Taye, Mulugeta Sitot Shibeshi, Negash Tagesse

Publikováno v: International Medical Case Reports Journal. 15:393-397

Worku Ketema,1 Kindie Woubishet,2 Sisay Tesfaye,2 Selamawit Gutema,2 Kefyalew Taye,1 Mulugeta Sitot Shibeshi,1 Negash Tagesse1 1Department of Pediatrics and Child Health, College of Health Sciences, Hawassa University, Hawassa, Sidama, Ethiopia; 2Dep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be3eb8f1beb04703ca6a16d92fb7cdc
https://doi.org/10.2147/imcrj.s373197

Zobrazit plný text záznamu

The First Experience of Effective 3rd Line Antiretroviral Therapy – A Case of 40-Year-Old Female Retroviral-Infected Patient at Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia

Autor: Worku Ketema, Agete Tadewos Hirigo, Alemayehu Toma, Mulugeta Sitot Shibeshi, Negash Tagesse, Selamawit Gutema, Aberash Eifa, Kefyalew Taye, Kindie Woubishet

Publikováno v: Research and Reports in Tropical Medicine

Background Treatment failure continues to be an impediment to the efficacy of highly active antiretroviral therapy (HART) in the treatment of human immunodeficiency virus type 1 infection (HIV-1). The World Health Organization (WHO) recommends third-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17c9292682197ebdc01f51e3a0030ad
http://europepmc.org/articles/PMC8631462

Zobrazit plný text záznamu

Trends of Immuno-virological Response Among HIV-Infected Patients Receiving Highly Active Anti-retroviral Therapy at Hawassa, Southern Ethiopia

Autor: Selamawit Gutema Bule, Demissie Assegu Fenta, Tadewos Beyene Bala, Meseret Regassa Gemechu, Agete Tadewos Hirigo

Publikováno v: Clinical Medicine Research. 4:104

Background: Immunological and virological response evaluation is one of a critical tool for assessing treatment outcome, regimen change and patient’s management. However, data concerning any change in immunological and virological response in HIV i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f9a50a62d3dbfe6adeaea3b56f6bfd2b
https://doi.org/10.11648/j.cmr.20150404.13

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání